10 research outputs found

    Multicomponent Assemblies: Structural Studies of Complex Filaments

    No full text
    Protein polymers play essential roles in cell biology. In response to diverse events, cytosolic proteins can assemble into filaments with a range of properties. The foci of this dissertation are two different kinds of multicomponent filaments. In the first section, I describe a filamentous assembly of dynamin1 and endophilinA1 and the roles these proteins play during endocytosis. The second section concerns a copolymer that comprises Increased Sodium Tolerance 1 (IST1) with CHarged Multivesicular Body Protein 1B (CHMP1B) and the distinct roles of this coassembly on endosomal membranes and on exposed DNA present during the cell cycle. I employed biochemical, structural, and cell biological approaches to investigate how these proteins copolymerize and the functional properties of their resulting filaments. The dissertation concludes with key mechanistic insights into the features of these filaments and predicts that membrane-remodeling proteins may also serve as nucleic acid-binding or cytoskeleton-binding proteins by exploiting surfaces common to both processes

    Inhibiting HTLV-1 Protease: A Viable Antiviral Target

    No full text
    Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that can cause severe paralytic neurologic disease and immune disorders as well as cancer. An estimated 20 million people worldwide are infected with HTLV-1, with prevalence reaching 30% in some parts of the world. In stark contrast to HIV-1, no direct acting antivirals (DAAs) exist against HTLV-1. The aspartyl protease of HTLV-1 is a dimer similar to that of HIV-1 and processes the viral polyprotein to permit viral maturation. We report that the FDA-approved HIV-1 protease inhibitor darunavir (DRV) inhibits the enzyme with 0.8 muM potency and provides a scaffold for drug design against HTLV-1. Analogs of DRV that we designed and synthesized achieved submicromolar inhibition against HTLV-1 protease and inhibited Gag processing in viral maturation assays and in a chronically HTLV-1 infected cell line. Cocrystal structures of these inhibitors with HTLV-1 protease highlight opportunities for future inhibitor design. Our results show promise toward developing highly potent HTLV-1 protease inhibitors as therapeutic agents against HTLV-1 infections

    HIV-2 Immature Particle Morphology Provides Insights into Gag Lattice Stability and Virus Maturation

    Get PDF
    Retrovirus immature particle morphology consists of a membrane enclosed, pleomorphic, spherical and incomplete lattice of Gag hexamers. Previously, we demonstrated that human immunodeficiency virus type 2 (HIV-2) immature particles possess a distinct and extensive Gag lattice morphology. To better understand the nature of the continuously curved hexagonal Gag lattice, we have used the single particle cryo-electron microscopy method to determine the HIV-2 Gag lattice structure for immature virions. The reconstruction map at 5.5 Å resolution revealed a stable, wineglass-shaped Gag hexamer structure with structural features consistent with other lentiviral immature Gag lattice structures. Cryo-electron tomography provided evidence for nearly complete ordered Gag lattice structures in HIV-2 immature particles. We also solved a 1.98 Å resolution crystal structure of the carboxyl-terminal domain (CTD) of the HIV-2 capsid (CA) protein that identified a structured helix 12 supported via an interaction of helix 10 in the absence of the SP1 region of Gag. Residues at the helix 10-12 interface proved critical in maintaining HIV-2 particle release and infectivity. Taken together, our findings provide the first 3D organization of HIV-2 immature Gag lattice and important insights into both HIV Gag lattice stabilization and virus maturation.This work is supported by NIH grant R01 AI177264 (to L.M. and W.Z.). Support is also acknowledged from NIH grants R35 GM118047 (to H.A.) and R21 AI148328 (to W.Z. and L.M.). D.C.D. acknowledges the support of the grant 205321/179041 of the Swiss National Science Foundation (SNF), the grant RGP0017/2020 of the Human Frontiers Science Program (HFSP), and funding from the project PID2021-127309NB-I00 funded by AEI/10.13039/501100011033/ FEDER, UE. This research was, in part, supported by the National Cancer Institute’s National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research under contract HSSN261200800001E. Parts of this work were carried out in the Characterization Facility, University of Minnesota, which receives partial support from the NSF through the MRSEC (Award Number DMR-2011401) and the NNCI (Award Number ECCS-2025124) programs.N.T. was supported by NIH grants T32 DA007097, F32 AI150351, and American Cancer Society Postdoctoral Fellowship PF-21-189-01-MPC. W.G.A. was supported by the Institute for Molecular Virology Training Program (i.e., NIH grant T32 AI83196).Peer reviewe

    Structure and membrane remodeling activity of ESCRT-III helical polymers.

    No full text
    The endosomal sorting complexes required for transport (ESCRT) proteins mediate fundamental membrane remodeling events that require stabilizing negative membrane curvature. These include endosomal intralumenal vesicle formation, HIV budding, nuclear envelope closure, and cytokinetic abscission. ESCRT-III subunits perform key roles in these processes by changing conformation and polymerizing into membrane-remodeling filaments. Here, we report the 4 angstrom resolution cryogenic electron microscopy reconstruction of a one-start, double-stranded helical copolymer composed of two different human ESCRT-III subunits, charged multivesicular body protein 1B (CHMP1B) and increased sodium tolerance 1 (IST1). The inner strand comprises "open" CHMP1B subunits that interlock in an elaborate domain-swapped architecture and is encircled by an outer strand of "closed" IST1 subunits. Unlike other ESCRT-III proteins, CHMP1B and IST1 polymers form external coats on positively curved membranes in vitro and in vivo. Our analysis suggests how common ESCRT-III filament architectures could stabilize different degrees and directions of membrane curvature
    corecore